1. Home
  2. FORM vs RGEN Comparison

FORM vs RGEN Comparison

Compare FORM & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FormFactor Inc. FormFactor Inc.

FORM

FormFactor Inc. FormFactor Inc.

HOLD

Current Price

$127.85

Market Cap

7.1B

Sector

Technology

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$126.69

Market Cap

6.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FORM
RGEN
Founded
1993
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.1B
6.6B
IPO Year
2002
1995

Fundamental Metrics

Financial Performance
Metric
FORM
RGEN
Price
$127.85
$126.69
Analyst Decision
Buy
Buy
Analyst Count
9
11
Target Price
$91.63
$170.18
AVG Volume (30 Days)
1.5M
748.4K
Earning Date
04-29-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
286.96
EPS
0.69
0.86
Revenue
N/A
$141,236,000.00
Revenue This Year
$19.43
$14.30
Revenue Next Year
$7.31
$14.52
P/E Ratio
$188.04
$153.62
Revenue Growth
N/A
35.10
52 Week Low
$23.79
$109.66
52 Week High
$136.00
$175.77

Technical Indicators

Market Signals
Indicator
FORM
RGEN
Relative Strength Index (RSI) 72.29 55.88
Support Level $90.63 $111.29
Resistance Level N/A $130.56
Average True Range (ATR) 6.75 4.50
MACD 2.38 2.33
Stochastic Oscillator 81.90 70.32

Price Performance

Historical Comparison
FORM
RGEN

About FORM FormFactor Inc. FormFactor Inc.

FormFactor Inc is a provider of electrical and optical test and measurement technologies along the full semiconductor product lifecycle - from characterization, modeling, reliability, and design de-bug, to qualification and production test.. The company operates in two reportable segments namely Probe Cards Segment and the Systems Segment. Sales of probe cards and analytical probes are included in the Probe Cards Segment, while sales of probe stations and thermal sub-systems are included in the Systems Segment. Probe cards generate the maximum revenue from its operations. It offers multiple product lines which include analytical probes, probe stations, thermal sub-systems, and related services.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: